Home : August 2019 : August 28, 2019 News : Medivir AB - Interim Report January - June 2019

Medivir AB - Interim Report January - June 2019

August 28, 2019

STOCKHOLM, Aug. 28, 2019 /PRNewswire/ -- April – June Significant events during the quarter Selective effect signal on liver cancer tissue in phase Ia study with MIV-818. The analysis shows an early indication that MIV-818 works as expected, i.e. the substance has the intended...

https://www.prnewswire.com:443/news-releases/medivir-ab--interim-report-january--june-2019-300908276.html
Other Stories